The University of Chicago Header Logo

Connection

Nishant Agrawal to Neoadjuvant Therapy

Back to Details
This is a "connection" page, showing publications Nishant Agrawal has written about Neoadjuvant Therapy.
Nishant Agrawal
Connection Strength
0.188
Neoadjuvant Therapy
  1. Neoadjuvant Nivolumab Plus Chemotherapy Followed By Response-Adaptive Therapy for HPV+ Oropharyngeal Cancer: OPTIMA II Phase 2 Open-Label Nonrandomized Controlled Trial. JAMA Oncol. 2024 Jul 01; 10(7):923-931.
    View in: PubMed
    Score: 0.188
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.